These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 30208295

  • 1. Motor deficits in 16-month-old male and female 3xTg-AD mice.
    Garvock-de Montbrun T, Fertan E, Stover K, Brown RE.
    Behav Brain Res; 2019 Jan 01; 356():305-313. PubMed ID: 30208295
    [Abstract] [Full Text] [Related]

  • 2. Analysis of motor function in 6-month-old male and female 3xTg-AD mice.
    Stover KR, Campbell MA, Van Winssen CM, Brown RE.
    Behav Brain Res; 2015 Mar 15; 281():16-23. PubMed ID: 25486177
    [Abstract] [Full Text] [Related]

  • 3. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
    Fertan E, Wong AA, Vienneau NA, Brown RE.
    Behav Brain Res; 2019 Sep 16; 370():111937. PubMed ID: 31121220
    [Abstract] [Full Text] [Related]

  • 4. Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer's disease.
    O'Leary TP, Robertson A, Chipman PH, Rafuse VF, Brown RE.
    Behav Brain Res; 2018 Jan 30; 337():256-263. PubMed ID: 28890389
    [Abstract] [Full Text] [Related]

  • 5. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.
    Perez SE, He B, Muhammad N, Oh KJ, Fahnestock M, Ikonomovic MD, Mufson EJ.
    Neurobiol Dis; 2011 Feb 30; 41(2):338-52. PubMed ID: 20937383
    [Abstract] [Full Text] [Related]

  • 6. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
    Kapadia M, Mian MF, Michalski B, Azam AB, Ma D, Salwierz P, Christopher A, Rosa E, Zovkic IB, Forsythe P, Fahnestock M, Sakic B.
    J Alzheimers Dis; 2018 Feb 30; 63(3):1191-1205. PubMed ID: 29710702
    [Abstract] [Full Text] [Related]

  • 7. [The improvement effect of scFv17 on the gait of triple-transgenic mice].
    Wang T, Cao Y, Hu MM, Zhang XM, Dong XF, Qi JS, Zhang J, Yang W.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 May 08; 34(5):389-395. PubMed ID: 30788916
    [Abstract] [Full Text] [Related]

  • 8. Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease.
    Stover KR, Campbell MA, Van Winssen CM, Brown RE.
    Behav Brain Res; 2015 Aug 01; 289():29-38. PubMed ID: 25896362
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J, Lebbadi M, Tremblay C, St-Amour I, Pierrisnard C, Faucher-Genest A, Emond V, Julien C, Calon F.
    Synapse; 2018 Apr 01; 72(4):. PubMed ID: 29341269
    [Abstract] [Full Text] [Related]

  • 10. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice.
    Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Oddo S.
    Aging Cell; 2019 Feb 01; 18(1):e12873. PubMed ID: 30488653
    [Abstract] [Full Text] [Related]

  • 11. Reference and working memory deficits in the 3xTg-AD mouse between 2 and 15-months of age: a cross-sectional study.
    Stevens LM, Brown RE.
    Behav Brain Res; 2015 Feb 01; 278():496-505. PubMed ID: 25446812
    [Abstract] [Full Text] [Related]

  • 12. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H, Kishimoto Y, Kawai N, Toyota Y, Ueno M, Kubota T, Kirino Y, Tamiya T.
    Neurosci Lett; 2016 Aug 26; 629():62-67. PubMed ID: 27373531
    [Abstract] [Full Text] [Related]

  • 13. Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Robison LS, Gannon OJ, Salinero AE, Abi-Ghanem C, Kelly RD, Riccio DA, Mansour FM, Zuloaga KL.
    Biol Sex Differ; 2023 Aug 09; 14(1):51. PubMed ID: 37559092
    [Abstract] [Full Text] [Related]

  • 14. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM, Dodacki A, Alata W, Calon F, Nicolic S, Scherrmann JM, Farinotti R, Bourasset F.
    J Alzheimers Dis; 2016 Aug 09; 49(2):287-300. PubMed ID: 26484906
    [Abstract] [Full Text] [Related]

  • 15. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
    Kong V, Devenyi GA, Gallino D, Ayranci G, Germann J, Rollins C, Chakravarty MM.
    Brain Struct Funct; 2018 Sep 09; 223(7):3365-3382. PubMed ID: 29948190
    [Abstract] [Full Text] [Related]

  • 16. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Sep 09; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    ACS Chem Neurosci; 2017 Mar 15; 8(3):676-685. PubMed ID: 28032988
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
    Vandini E, Ottani A, Zaffe D, Calevro A, Canalini F, Cavallini GM, Rossi R, Guarini S, Giuliani D.
    Pharmacology; 2019 Mar 15; 103(1-2):50-60. PubMed ID: 30448835
    [Abstract] [Full Text] [Related]

  • 19. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A, Aoyama Y, Shin EJ, Nam Y, Kim HC, Nagai T, Yokosuka A, Mimaki Y, Yokoi T, Ohizumi Y, Yamada K.
    Behav Brain Res; 2015 Aug 01; 289():69-77. PubMed ID: 25913833
    [Abstract] [Full Text] [Related]

  • 20. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.
    Romano A, Pace L, Tempesta B, Lavecchia AM, Macheda T, Bedse G, Petrella A, Cifani C, Serviddio G, Vendemiale G, Gaetani S, Cassano T.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(4):. PubMed ID: 25609597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.